FernandaDe PinhoSilveiraMD
Infectious Disease • Pittsburgh, PAProfessor of Medicine, University of Pittsburgh School of Medicine
Dr. Silveira is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 Fifth Avenue
# 700
Pittsburgh, PA 15213Phone+1 412-647-7228Fax+1 412-647-3162
Education & Training
UPMC Medical EducationFellowship, Infectious Disease, 2003 - 2005
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2000 - 2003
Faculdade de Medicina da Universidade Federal do Rio de JaneiroClass of 1998
Certifications & Licensure
PA State Medical License 2003 - 2024- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Invasive Fungal Infections Surveillance Initiative Start of enrollment: 2005 Aug 01
- Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036) Start of enrollment: 2008 Jun 01
- Infectious Outcomes Following Pancreas Transplantation Start of enrollment: 2006 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- The Post-transplant Lymphoproliferative Disorders-Metagenomic Shotgun Microbial Sequencing (PTLD-MSMS) Study Methods and Protocol.Vikas R Dharnidharka, Kristine M Wylie, Todd N Wylie, Marianna B Ruzinova, Charles W Goss
Transplantation Direct. 2024-11-01 - 1 citationsInvasive aspergillosis in liver transplant recipients in the current era.Muneyoshi Kimura, Matteo Rinaldi, Sagar Kothari, Maddalena Giannella, Shweta Anjan
American Journal of Transplantation. 2024-11-01 - 2 citationsManagement of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel.Me-Linh Luong, Yoshiko Nakamachi, Fernanda P Silveira, Catherine O Morrissey, Lara Danziger-Isakov
Transplant Infectious Disease. 2024-06-01
Press Mentions
Takeda Announces Publication of Data from SOLSTICE, a Pivotal Phase 3 Trial for LIVTENCITY™ (Maribavir) in Post-Transplant Recipients with Cytomegalovirus (CMV) Infection (Refractory, with or Without Resistance)December 7th, 2021
More Organs Available for Transplant Because of Opioid EpidemicApril 18th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
